Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950298 · ClinicalTrials.gov registry record
Pompe Telemedicine Developmental Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 22
- Enrollment target
NCT02950298 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 22 participants.
The verdict
NCT02950298 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The primary purpose of this study is to: * Document the developmental outcomes of individuals with Pompe disease treated with long-term enzyme-replacement therapy (ERT) through school-age (ages 6-18) using measures of cognitive functioning, academic skills, and speech and language abilities. * Investigate possible cognitive processing speed weaknesses using BrainBaseline neurocognitive assessment software. * Investigate the relationship between behavior and other developmental factors including speech and language ability and cognitive ability. * Explore if the use of selected iPad applications may help strengthen cognitive processing speed in children with Pompe disease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-12 |
| Est. Completion | 2021-03-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02950298
The ClinicalTrials.gov registry entry for NCT02950298 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02950298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02950298 about?
NCT02950298 is a clinical study titled "Pompe Telemedicine Developmental Study". The primary purpose of this study is to: * Document the developmental outcomes of individuals with Pompe disease treated with long-term enzyme-replacement therapy (ERT) through school-age (ages 6-18) using measures of cognitive functioning, academic skills, and speech and language abilities. * Inve...
What is the current status of trial NCT02950298?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2015-12. Estimated completion is 2021-03-03.
Who is sponsoring clinical trial NCT02950298?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.